- Home
- RGP vs RZLT Comparison
RGP vs RZLT Comparison
Compare RGP & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGP
- RZLT
- Stock Information
- Founded
- RGP 1996
- RZLT 2010
- Country
- RGP United States
- RZLT United States
- Employees
- RGP N/A
- RZLT N/A
- Industry
- RGP Business Services
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- RGP Consumer Discretionary
- RZLT Health Care
- Exchange
- RGP Nasdaq
- RZLT Nasdaq
- Market Cap
- RGP 178.9M
- RZLT 361.3M
- IPO Year
- RGP 2006
- RZLT N/A
- Fundamental
- Price
- RGP $5.45
- RZLT $5.32
- Analyst Decision
- RGP Sell
- RZLT Strong Buy
- Analyst Count
- RGP 1
- RZLT 6
- Target Price
- RGP $5.00
- RZLT $12.00
- AVG Volume (30 Days)
- RGP 214.1K
- RZLT 1.4M
- Earning Date
- RGP 07-21-2025
- RZLT 05-13-2025
- Dividend Yield
- RGP 5.11%
- RZLT N/A
- EPS Growth
- RGP N/A
- RZLT N/A
- EPS
- RGP N/A
- RZLT N/A
- Revenue
- RGP $560,189,000.00
- RZLT N/A
- Revenue This Year
- RGP N/A
- RZLT $35.39
- Revenue Next Year
- RGP $3.85
- RZLT N/A
- P/E Ratio
- RGP N/A
- RZLT N/A
- Revenue Growth
- RGP N/A
- RZLT N/A
- 52 Week Low
- RGP $4.81
- RZLT $2.22
- 52 Week High
- RGP $12.19
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- RGP 46.37
- RZLT 75.51
- Support Level
- RGP $5.23
- RZLT $4.15
- Resistance Level
- RGP $6.14
- RZLT $5.39
- Average True Range (ATR)
- RGP 0.23
- RZLT 0.31
- MACD
- RGP -0.01
- RZLT 0.08
- Stochastic Oscillator
- RGP 20.56
- RZLT 91.84
About RGP Resources Connection Inc.
Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.